Koss Olinger Consulting, LLC Amgen Inc Transaction History

Koss Olinger Consulting, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	BUY	$268.87 - $324.56 $1 Million - $1.21 Million	3,736 New	3,736 $1.06 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $608,578 - $713,022	-2,867 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $25,927 - $28,764	111 Added 4.03%	2,867 $699,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $611,583 - $712,701	2,756 New	2,756 $686,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

Stay updated on Koss Olinger Consulting, LLC with notifications on news.